Riskpilot← Back to searchSign inGet full accessR.S. Medicus AB
ABActiveOrg 5591583082Parmmätargatan 9 AGeneral medical practice activities · NACE 8621Est. 20181 employees
Revenue 2024
SEK 0
EBITDA margin
—
+72% vs 2023
Equity ratio
110.1%
Financial strength
Net profit 2024
SEK -6K
+74% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -7K | +72% |
| Net profit | SEK -6K | +74% |
| Total assets | SEK 272K | -12% |
| Equity | SEK 299K | -2% |
| Employees | 1 | — |
Legal name
R.S. Medicus AB
Org number
5591583082
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 maj 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet ska bestå i att bedriva öppen hälso- och sjukvård, förmedling, bemanning och rekryteringsverksamhet inom vård och omsorg samt därmed förenlig verksamhet. Vidare ska bolaget äga, förvalta och bedriva handel med värdepapper och fast egendom, samt bedriva annan därmed förenlig verksamhet.
Address
Parmmätargatan 9 A
Email
roba.said@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 103 | 135 | 20 | 0 | 0 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 79 | 111 | 8 | −23 | −7 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 79 | 111 | 8 | −23 | −7 |
| Net financials | — | — | −1 | 0 | 1 |
| Profit before tax | 79 | 111 | 7 | −23 | −6 |
| Tax | −17 | −24 | −1 | — | — |
| Net profit | 62 | 87 | 5 | −23 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 263 | 356 | 334 | 308 | 272 |
| Equity | 236 | 323 | 328 | 305 | 299 |
| Long-term debt | 0 | 2 | 3 | 3 | 3 |
| Short-term debt | 27 | 31 | 4 | 0 | −30 |
| Total debt | 27 | 33 | 6 | 3 | −27 |
EBITDA margin
-650800.0%
This company
15.8%
Market median
-4119087% vs market
20202024
Equity ratio
110.1%
This company
38.2%
Market median
+188% vs market
20202024
Return on equity
-2.0%
This company
18.4%
Market median
-111% vs market
20202024
Net profit margin
-598800.0%
This company
8.1%
Market median
-7392693% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-0.09×
This company
0.62×
Market median
+115% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.